» » »

Gene Mutation and Endometrial Cancer Durham NC

A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments. The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women#r3 with a highly aggressive form of the disease known as endometrioid endometrial cancer.

Donald Serafin
(919) 684-3347
1110 West Main Street
Durham, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
21st Century Wellness Solutions
(919) 477-6330
3328 Guess Road, Suite # 1A
Durham, NC

Data Provided by:
Kruse Chiropractic
(919) 474-8400
5410 Page Rd
Durham, NC

Data Provided by:
North Paw Animal Hospital
(919) 471-1471
5106 Guess Rd
Durham, NC

Data Provided by:
Cole Park Veterinary Hospital
(919) 929-3352
11500 Highway 15-501 North
Chapel Hill, NC

Data Provided by:
Cary N Robertson MD
(919) 681-6788
DUMC 3833
Durham, NC
Specialties
Urology

Data Provided by:
Colony Park Animal Hospital
(919) 489-9156
3102 Sandy Creek Dr
Durham, NC

Data Provided by:
Ellingson Family Chiropractic
(919) 443-1861
5410 NC Highway 55 # E
Durham, NC

Data Provided by:
Sidney C Smith Jr., MD
(919) 966-5201
130 Mason Farm Rd
Chapel Hill, NC
Business
UNC Cardiology
Specialties
Cardiology

Data Provided by:
Village Veterinary Hospital
(919) 967-4779
50150 Governors Dr
Chapel Hill, NC

Data Provided by:
Data Provided by:

Gene Mutation and Endometrial Cancer

Provided By:

WEDNESDAY, May 27 (HealthDay News) -- A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments.

The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women with a highly aggressive form of the disease known as endometrioid endometrial cancer.

The ATR gene directs cellular responses to DNA damage, the researchers noted.

"Women whose endometrial cancers have an ATR mutation have more than four times the risk of having their cancer return," study author Dr. Israel Zighelboim, a gynecologic oncologist, said in a news release from the university. "This and similar tumor biomarkers could potentially identify those patients most in danger of recurrence and guide the development of treatments aimed at these more aggressive tumors."

ATR mutations were found in about 5 percent of the 248 endometrioid endometrial tumor samples analyzed by the researchers. Women with ATR mutations were 4.29 times more likely to have the cancer recur after treatment and 3.88 times more likely to die.

The study appears online in the Journal of Clinical Oncology.

Zighelboim and his research colleagues plan to see if the prognostic value of ATR mutations can be confirmed in a larger group of women and to investigate the association between ATR mutations and treatment response after cancer recurrence.

More information

The American Cancer Society has more about endometrial cancer.

SOURCE: Washington University School of Medicine in St. Louis, news release, May 26, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com